Skip to main content

Table 5 Risk of cardiovascular disease among HIV-infected individuals exposed to abacavir for various durations

From: Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

Duration of exposure (months)

HR (95% CI; p value) Unadjusted Cox Model

Adjusted Cox Model HRa (95% CI; p value)

Marginal Structural Model HRb (95% CI; p value)

Never exposed

Referent

Referent

Referent

1–6

1.66 (1.23, 2.25; p = 0.001)

1.24 (0.92, 1.67; p = 0.163)

1.25 (0.92, 1.70; p = 0.150)

7–12

1.69 (1.15, 2.47; p = 0.007)

1.27 (0.87, 1.86; p = 0.219)

1.41 (0.97, 2.06; p = 0.073)

13–18

2.28 (1.48, 3.54; p < 0.001)

1.71 (1.10, 2.65; p = 0.016)

1.78 (1.16, 2.72; p = 0.009)

19–24

2.09 (1.26, 3.47; p = 0.004)

1.62 (0.98, 2.69; p = 0.060)

1.90 (1.16, 3.11; p = 0.011)

>25

1.45 (0.97, 2.18; p = 0.071)

1.20 (0.80, 1.80; p = 0.386)

1.30 (0.86, 1.97; p = 0.208)

  1. aAdjusted for baseline covariates: gender, tobacco use (ever), substances or alcohol abuse (ever), symptomatic HIV disease, serologic evidence of hepatitis B & C infections, history of stroke, history of cancer, prior myocardial infarction, and time-dependent covariates: age, calendar year, body weight, receipt of anti-hyperglycemic agents, receipt of medications for heart disease, and diagnoses of: diabetes mellitus, chronic kidney disease, dyslipidemia, heart failure, cardiac dysrhythmia, atherosclerosis, and hypertension
  2. bIn addition to adjusting for weights generated from the treatment model using all the time-fixed and time-dependent covariates in the adjusted Cox model, the marginal model is adjusted for time-fixed/baseline covariates: sex, ever tobacco use, ever alcohol or substance abuse, symptomatic HIV disease, serologic evidence of hepatitis B & C infections, history of stroke, history of cancer, prior myocardial infarction, and baseline values of time-dependent covariates: age, calendar year, receipt of anti-hyperglycemic agents, receipt of medications for heart disease, and diagnoses of: diabetes mellitus, chronic kidney disease, dyslipidemia, heart failure, cardiac dysrhythmia, atherosclerosis, and hypertension
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us